Our “Regeneration-inducing Medicine” is a next-generation regenerative medicine that realizes the same therapeutic effect as conventional regenerative medicine/cell therapy only through drug administration without using living cells and tissues.
Inherently, organisms are equipped with the ability to repair their damaged tissues due to injury or illness. This ability is carried by the tissue stem cells existing in organisms, which can differentiate into various tissues with multipotent ability. In damaged tissues, such tissue stem cells proliferate and differentiate to promote functional tissue regeneration.
Our “Regeneration-inducing Medicine” aims to maximize the efficiency of this innate tissue regeneration capability.
Regeneration-inducing Medicine promotes tissue regeneration by increasing the supply of tissue stem cells, forming the basis of this tissue regeneration mechanism.
Specifically, one of the most developed regeneration-inducing drugs in the laboratory at present is to release (mobilize) mesenchymal stem cells existing in the bone marrow into the peripheral circulating bloodstream by its administration. By doing so, it has the function of accelerating the reconstruction of damaged tissue by increasing the amount of stem cells circulating in the body and accumulating it in the damaged tissue.
The concept of Regeneration-inducing Medicine is to promote functional tissue regeneration utilizing the innate tissue repairing ability with the patient’s own stem cells in the body.
therapies StemRIM is developing
- Disorders of various organs and tissues
- Regeneration-inducing medicine administered
- Stem cells mobilized from the bone marrow to the blood stream
- Stem cells accumulate in the damaged tissues
- Functional regeneration is induced